Role of ABeta in neural synapse and circuit remodeling following general anesthes
Aβ 在全身麻醉后神经突触和回路重塑中的作用
基本信息
- 批准号:8778370
- 负责人:
- 金额:$ 26.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:A MouseAge-YearsAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAnesthesia proceduresAnestheticsAreaBehavioralBiochemicalBrainCaringCerebrumClinicalClinical ResearchCognitiveDeliriumDementiaDendritic SpinesElderlyEnzyme-Linked Immunosorbent AssayFluorescence MicroscopyFunctional disorderGeneral AnesthesiaGeneral anesthetic drugsHealthHippocampus (Brain)ImageImmediate-Early GenesImpaired cognitionImpairmentIsofluraneLearningMediatingMemoryMemory impairmentModelingMorbidity - disease rateMorphologyMusNeurobehavioral ManifestationsNeuronsNeuropathogenesisOperative Surgical ProceduresPatientsPatternPlayProcessProgressive DiseaseProteinsPsyche structureReporterResearchResearch PersonnelRodentRoleSenile PlaquesStaining methodStainsSynapsesTestingTimeTransgenic MiceVenusVertebral columnWorkadverse outcomedensitydentate gyrusdesfluraneexperienceimprovedinhibitor/antagonistmild cognitive impairmentmorris water mazeneural circuitneuronal patterningolder patientoverexpressionpreclinical studypromoterrelating to nervous systemsecretasesynaptic depression
项目摘要
DESCRIPTION (provided by applicant): Nearly 40% of surgical procedures are performed on patients 65 years of age or older and cognitive complications are common. General anesthesia has been implicated and seniors worry that the anesthesia might cause permanent memory problems or even dementia. Clinical studies are inconclusive but preclinical studies show that some general anesthetic agents produce prolonged memory impairment and promote Alzheimer's disease (AD)-like biochemical changes in the brain. In particular, the commonly used volatile anesthetic isoflurane rapidly increases amyloid β (Aβ), a protein strongly implicated in the neuropathogenesis of Alzheimer's disease, and causes long-lasting memory impairment, whereas desflurane, also widely used, does neither. Further, the biochemical changes are exaggerated in AD transgenic mice that have elevated levels of cerebral Abeta at baseline, implying pre-existing cerebral amyloid may be a vulnerability factor for anesthetic-induced cognitive decline. Mounting evidence indicates AD is primarily a disease of progressive synaptic dysfunction and loss that results in both synaptic depression and aberrant patterns of neuronal network activity, with oligomeric Abeta playing a major role in the process. However, no studies have investigated the impact of an anesthetic- induced increase in Abeta on neural synapses and networks. We propose to do so here, using isoflurane and desflurane anesthesia and Arc::dVenus reporter mice and Arc:dVenus/PS1 AD transgenic mice as models, respectively, of the 'normal' and Abeta-burdened brain. Arc is an immediate early gene that is a central regulator of dendritic spine dynamics and experience-dependent plasticity and Arc:dVenus mice overexpress destabilized Venus (dVenus) under control of the Arc promoter, allowing experience-evoked activity in spines and neurons to be directly visualized by fluorescence microscopy. We hypothesize that an increase in Abeta after isoflurane anesthesia has different consequences in the healthy vs. Abeta-burdened brain. We propose that an isoflurane-induced increase in Abeta causes collapse of dendritic spines (Aim 1) and 2. Generates abnormal patterns of experienced-evoked activity in hippocampal neural circuits (Aim 2) when the pre-existing amyloid burden is high but not otherwise, and that desflurane has no effect. This research is significant scientifically because it will clarify the functional consequences of anesthetic-induced increases in Abeta. Furthermore, because 1 in 3 older adults without cognitive symptoms, and most of those with mild cognitive impairment (MCI) or AD, have elevated amyloid at baseline, this work could have vast clinical implications for improving anesthetic care and reducing cognitive morbidity in geriatric surgical patients.
描述(由适用提供):将近40%的手术程序是对65岁或以上的患者进行的,并且认知并发症很常见。已经暗示了全身麻醉,老年人担心麻醉可能导致永久性记忆问题甚至痴呆症。临床研究尚无定论,但临床前研究表明,某些一般麻醉剂会导致长时间的记忆力障碍,并促进阿尔茨海默氏病(AD)类似大脑的生物化学变化。特别是,常用的挥发性麻醉性异氟烷会迅速增加淀粉样β(Aβ),淀粉样β(Aβ)强烈与阿尔茨海默氏病的神经性发作有关,造成长期持久记忆障碍,并且持续的记忆障碍,而desflurane(也广泛使用)也没有。此外,在基线时脑abeta水平升高的AD转基因小鼠中,生化变化被夸大了,这表明先前存在的脑淀粉样蛋白可能是麻醉诱导认知能力下降的脆弱性因子。越来越多的证据表明,AD主要是一种进行性突触功能障碍和丧失的疾病,导致突触抑郁症和神经元网络活动的异常模式,而低聚的ABETA在此过程中起着重要作用。但是,尚无研究研究Anisothetic诱导的Abeta对神经元突触和网络的影响。我们建议在这里这样做,使用异氟烷和desflurane麻醉和Arc :: Dvenus Reporter小鼠和Arc:dvenus/ps1 AD转基因小鼠作为模型,分别是“正常”和Abeta含有的大脑的模型。 ARC是一个直接的早期基因,是树突状脊柱动力学和经验依赖性可塑性和弧形的中心调节因子:Dvenus小鼠过表达在电弧启动子控制下不稳定的金星(Dvenus),从而使经验丰富的活性在棘突和神经元中被荧光显微镜直接化。我们假设异氟烷麻醉后ABETA的增加在健康与ABETA负担的大脑中会产生不同的后果。我们提出,异氟烷引起的Abeta升高会导致树突状棘的崩溃(AIM 1)和2。当预先存在的淀粉样蛋白负担很高,但没有效应时,在海马神经元回路中会产生异常的经验诱发活性模式(AIM 2)。这项研究在科学上是显着的,因为它将阐明麻醉引起的ABETA增加的功能后果。此外,由于三分之一没有认知症状的老年人,大多数患有轻度认知障碍(MCI)或AD的年轻人在基线时淀粉样蛋白升高,因此这项工作可能具有巨大的临床意义,可改善麻醉性护理,并降低色膜手术患者的认知性发病率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY CROSBY其他文献
GREGORY CROSBY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY CROSBY', 18)}}的其他基金
Preoperative Occult Neurodegeneration and Postoperative Delirium
术前隐匿性神经变性和术后谵妄
- 批准号:
10589054 - 财政年份:2022
- 资助金额:
$ 26.54万 - 项目类别:
Preoperative Occult Neurodegeneration and Postoperative Delirium
术前隐匿性神经变性和术后谵妄
- 批准号:
10367616 - 财政年份:2022
- 资助金额:
$ 26.54万 - 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
- 批准号:
7931508 - 财政年份:2009
- 资助金额:
$ 26.54万 - 项目类别:
Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
老年麻醉后中枢神经系统功能障碍的机制
- 批准号:
7056069 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
- 批准号:
7581845 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
老年麻醉后中枢神经系统功能障碍的机制
- 批准号:
6729968 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
- 批准号:
8056059 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
老年麻醉后中枢神经系统功能障碍的机制
- 批准号:
6883148 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
- 批准号:
8245821 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
- 批准号:
7774385 - 财政年份:2003
- 资助金额:
$ 26.54万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10451498 - 财政年份:2020
- 资助金额:
$ 26.54万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10618300 - 财政年份:2020
- 资助金额:
$ 26.54万 - 项目类别:
Repurposing of Universal and Immunogenic MultiTEP Platform Designed for AD to Develop SARS-CoV-2 Multiepitope Vaccine
重新利用专为 AD 设计的通用和免疫原性 MultiTEP 平台来开发 SARS-CoV-2 多表位疫苗
- 批准号:
10162389 - 财政年份:2019
- 资助金额:
$ 26.54万 - 项目类别:
ACTIVE IMMUNOTHERAPY FOR COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME
积极免疫疗法治疗成人唐氏综合症认知能力下降
- 批准号:
8750445 - 财政年份:2014
- 资助金额:
$ 26.54万 - 项目类别:
Mechanism of CREB dysregulation in Alzheimer brain
阿尔茨海默病大脑 CREB 失调的机制
- 批准号:
8803335 - 财政年份:2013
- 资助金额:
$ 26.54万 - 项目类别: